Semler Scientific ( (SMLR) ) has released its Q4 earnings. Here is a breakdown of the information Semler Scientific presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Semler Scientific, Inc. is a company known for developing technology products and services aimed at helping healthcare providers combat chronic diseases, with a notable focus on their proprietary arterial blood flow measurement test, QuantaFlo®. Recently, they have also embarked on a strategic investment in bitcoin as part of their treasury management.
In the latest earnings report for 2024, Semler Scientific demonstrated robust financial performance, particularly highlighting a substantial increase in their net income, which was reported at $40.9 million, nearly doubling from the previous year. This increase was largely driven by their strategic bitcoin investments, which have seen a significant rise in value.
Key financial metrics from the report include a revenue of $56.3 million, a reduction from the previous year, while costs were effectively managed, resulting in income from operations of $20.9 million. The company has embraced a bitcoin-focused treasury strategy, acquiring 3,192 bitcoins valued at approximately $300 million, which has led to a substantial increase in market capitalization.
Looking ahead, Semler Scientific remains committed to expanding its bitcoin holdings, viewing it as a strategic asset to enhance shareholder value. Despite a drop in traditional revenue streams, the company continues to focus on leveraging its healthcare technologies alongside its innovative investment strategies.
